Latest AI and machine learning research in skin cancer for healthcare professionals.
T cells are central to the adaptive immune response, capable of detecting pathogenic antigens while ignoring healthy tissues with remarkable specificity and sensitivity. Quantitatively understanding how T cell receptors discern among antigens requires biophysical models and theoretical analyses of signaling networks. Here, we review current theoretical frameworks of antigen recognition in the cont...
This review examines how biotechnology advances (CRISPR/Cas9, next-generation targeted therapies, nanotechnology-based drug delivery, and immunotherap...
Esophageal squamous cell carcinoma (ESCC) remains a major health burden, particularly in Asia, with poor patient prognosis despite advancements in rad...
Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, ranks as the fourth leading cause of cancer-associated mortality globall...
Tumor Mutational Burden (TMB) is a widely used biomarker for selecting cancer patients for immune checkpoint inhibitor (ICI) therapy. However, TMB alo...
Immune checkpoint inhibitors (ICI) have improved clinical outcomes for some patients with advanced NSCLC, however a substantial proportion of patients...
This study systematically predicts prognosis and key gene targets for immunotherapy in hepatocellular carcinoma (HCC) patients based on the joint scre...
PURPOSE OF REVIEW: Early diagnosis of skin cancer is essential for patient care. Noninvasive skin imaging devices have become increasingly used for th...
The epidermal growth factor receptor (EGFR) is a key target in cancer therapy, mainly in non-small cell lung cancer (NSCLC). Though, the efficacy of E...
The discovery of natural killer (NK) cells stands among the fundamental milestones in modern immunology. To mark the 50-year anniversary of the first ...
Recent advancements in cancer immunotherapy have transformed clinical oncology, with monoclonal antibodies (mAbs), immune checkpoint inhibitors, adopt...
Hepatocellular carcinoma (HCC) represents an extremely complex and heterogeneous malignant tumor. Protein palmitoylation, a highly conserved and pivot...
Ribonucleic acid (RNA) modifications, once viewed as static structural features, are now recognized as dynamic regulators of the 'epitranscriptome' th...
BACKGROUND: Uveal melanoma (UM) is a rare cancer with an estimated annual incidence of 6 incidences per million people. About half of UM patients deve...
Advancements in deep learning technologies and an increase in medical data have enhanced the accuracy of disease diagnosis and treatment strategies. N...
BACKGROUND: Hymenoptera venom immunotherapy is an established treatment for severe allergic reactions, aiming to modulate the immune response and redu...
In contrast to the MSI-H subtype, most microsatellite-stable (MSS) colorectal cancer (CRC) patients exhibit poor prognosis and limited responsiveness ...
Lung adenocarcinoma (LUAD) displays significant morphological and molecular heterogeneity both within and between tumors. This heterogeneity, coupled ...
Various exosome-derived proteins have been reported to play essential roles in regulating colorectal cancer progression and affecting the prognosis of...